SKINBIOTHERAPEUTICS PLC Logo

SKINBIOTHERAPEUTICS PLC

SBTX | IL

Overview

Corporate Details

ISIN(s):
GB00BF33H870
LEI:
213800YMQOCB23FX6I06
Country:
United Kingdom
Address:
THE CORE, NE4 5TF NEWCASTLE UPON TYNE
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

SkinBioTherapeutics PLC is a life science company advancing skin health through microbiome science. Its core activities center on the proprietary SkinBiotix® platform, a technology from The University of Manchester that harnesses the microbiome to protect and restore skin. The company commercializes its technology via in-house product development, such as the AxisBiotix probiotic food supplement for psoriasis, and through strategic acquisitions. Its subsidiaries, including Dermatonics and Bio-Tech Solutions, provide established product lines in dermatological and foot care, as well as formulation, manufacturing, and packaging services. SkinBioTherapeutics targets applications across five key sectors: Cosmetics, Food Supplements, Medical Devices, Hygiene, and Pharmaceuticals.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for SKINBIOTHERAPEUTICS PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 08:00
Earnings Release
FY Trading Update
English 21.6 KB
2025-06-30 08:00
Regulatory News Service
Croda Commercial Launch Progressing as Expected
English 16.2 KB
2025-06-27 08:00
Regulatory News Service
Notice of IMC Shareholder Presentation
English 15.4 KB
2025-06-25 12:28
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-06-20 08:00
Share Issue/Capital Change
Result of WRAP Retail Offer
English 28.1 KB
2025-04-07 18:34
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB
2025-03-26 08:00
Earnings Release
Half-year Report
English 194.4 KB
2025-02-26 10:00
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB
2025-02-24 08:00
Declaration of Voting Results & Voting Rights Announcements
Exercise of Warrants and Total Voting Rights
English 16.2 KB
2024-12-27 12:00
Post-Annual General Meeting Information
Result of AGM
English 11.5 KB
2024-12-12 15:45
Major Shareholding Notification
Holding(s) in Company
English 75.3 KB
2024-12-04 16:55
Report Publication Announcement
Posting of Annual Report and Notice of AGM
English 10.8 KB
2024-12-04 16:54
Earnings Release
Final Results
English 755.0 KB
2024-12-04 08:00
Report Publication Announcement
Notice of Results
English 11.9 KB
2024-11-29 12:00
Report Publication Announcement
Notice of Results
English 12.0 KB

Automate Your Workflow. Get a real-time feed of all SKINBIOTHERAPEUTICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SKINBIOTHERAPEUTICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Medesis Pharma S.A. Logo
Biotech creating CNS and oncology therapies using a proprietary drug delivery platform.
France ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
Biotech R&D firm developing novel drugs, devices, and therapies with a focus on oncology.
Poland MDB
Medigene AG Logo
An immuno-oncology platform creating T cell receptor (TCR)-guided therapies to treat cancer.
Germany MDG1
MedinCell S.A. Logo
Develops and licenses long-acting injectable therapies using proprietary technology.
France MEDCL
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR
Mendus Logo
Developing immunotherapies using dendritic cells to prevent recurrence of AML & ovarian cancer.
Sweden IMMU
Merck KGaA Logo United States of America 6MK
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Modus Therapeutics Holding AB Logo
Clinical-stage biotech developing sevuparin for sepsis, septic shock, and inflammation.
Sweden MODTX